Grace Nauman

Grace Nauman

Auto-generated profile, based on publicly available information

Grace Nauman

Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University , New York, NY

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2019 in Xenotransplantation
Verified
Journal Article
Closed access
PDF file
GNGrace Nauman
Grace Nauman
CBChiara Borsotti
Chiara Borsotti
NDNichole Danzl
Nichole Danzl
MKMohsen Khosravi‐Maharlooei
Mohsen Khosravi‐Maharlooei
HLHao‐Wei Li
Hao‐Wei Li
MSMegan Sykes
Megan Sykes

21 March 2022 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
GNGrace Nauman
Grace Nauman
NDNichole M. Danzl
Nichole M. Danzl
JLJaeyop Lee
Jaeyop Lee
CBChiara Borsotti
Chiara Borsotti
RMRachel Madley
Rachel Madley
MSMegan Sykes
Megan Sykes
Immunodeficient mice reconstituted with immune systems from patients, or personalized immune (PI) mice, are powerful tools for understanding human disease. Compared with immunodeficient mice transplanted with human fetal thymus tissue and fetal liver–derived CD34+ cells administered i.v. (Hu/Hu mice), PI mice, which are transplanted with human fetal thymus and adult bone marrow (aBM) CD34+ cells, demonstrate reduced levels of human reconstitution. We characterized APC and APC progenitor repopulation in human immune system mice and detected significant reductions in blood, bone marrow (BM), and splenic APC populations in PI compared with Hu/Hu mice. APC progenitors and hematopoietic stem cells (HSCs) were less abundant in aBM CD34+ cells compared with fetal liver–derived CD34+ cell preparations, and this reduction in APC progenitors was reflected in the BM of PI compared with Hu/Hu mice 14–20 wk posttransplant. The number of HSCs increased in PI mice compared with the originally infused BM cells and maintained functional repopulation potential, because BM from some PI mice 28 wk posttransplant generated human myeloid and lymphoid cells in secondary recipients. Moreover, long-term PI mouse BM contained functional T cell progenitors, evidenced by thymopoiesis in thymic organ cultures. Injection of aBM cells directly into the BM cavity, transgenic expression of hematopoietic cytokines, and coinfusion of human BM-derived mesenchymal stem cells synergized to enhance long-term B cell and monocyte levels in PI mice. These improvements allow a sustained time frame of 18–22 wk where APCs and T cells are present and greater flexibility for modeling immune disease pathogenesis and immunotherapies in PI mice.